Mycobacterial immunotherapy for prostate cancer: where can we go from here? (2020)
Attributed to:
Defining the microenvironmental contexture of the biopsy-naive, MRI-characterized prostate.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41585-020-0283-2
PubMed Identifier: 31996816
Publication URI: http://europepmc.org/abstract/MED/31996816
Type: Journal Article/Review
Volume: 17
Parent Publication: Nature reviews. Urology
Issue: 4
ISSN: 1759-4812